Dr. Ruberg's clinical and research expertise is in the field of cardiac imaging including echocardiography and cardiovascular magnetic resonance imaging (CMR). Dr. Ruberg applies imaging in research designed to facilitate improved diagnosis and management of the infiltrative cardiomyopathy cardiac amyloidosis.
Associate Professor
Boston University School of Medicine
Radiology
Program Director
Boston University School of Medicine
Clinical and Translational Science Institute
Pilot Translational & Clinical Studies Program
Active Staff Privileges
Boston Medical Center
Medicine
This tab shows grant data from BMC Sponsored Research. It includes:
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data from BU Sponsored Research. It includes:
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data that did not automatically get imported into Profiles from BU or BMC sources.
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
Molecular Imaging of Primary Amyloid Cardiomyopathy04/01/2017 - 03/31/2018 (PI)
The Brigham and Women's Hospital, Inc. NIH NHLBI5R01HL130563-02
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
login
to make corrections and additions.
-
Mints YY, Doros G, Berk JL, Connors LH, Ruberg FL. Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience. ESC Heart Fail. 2018 Jun 19.View Related Profiles. PMID: 29916559.
-
Siddiqi OK, Sanchorawala V, Ruberg FL. Echocardiography and Survival in Light Chain Cardiac Amyloidosis: Back to Basics. Circ Cardiovasc Imaging. 2018 May; 11(5):e007826.View Related Profiles. PMID: 29752394.
-
Martinez-Naharro A, Kotecha T, Norrington K, Boldrini M, Rezk T, Quarta C, Treibel TA, Whelan CJ, Knight DS, Kellman P, Ruberg FL, Gillmore JD, Moon JC, Hawkins PN, Fontana M. Native T1 and Extracellular Volume in Transthyretin Amyloidosis. JACC Cardiovasc Imaging. 2018 Mar 12. PMID: 29550324.
-
Jhaveri T, Sarosiek S, Ruberg FL, Siddiqi O, Berk JL, Sanchorawala V. Once AL amyloidosis: not always AL amyloidosis. Amyloid. 2018 Mar 08; 1-2.View Related Profiles. PMID: 29516761.
-
Phull P, Sanchorawala V, Connors LH, Doros G, Ruberg FL, Berk JL, Sarosiek S. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR). Amyloid. 2018 Mar; 25(1):62-67.View Related Profiles. PMID: 29424556.
-
Hanson JLS, Arvanitis M, Koch CM, Berk JL, Ruberg FL, Prokaeva T, Connors LH. Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin. Circ Heart Fail. 2018 Feb; 11(2):e004000.View Related Profiles. PMID: 29449366.
-
Maurer MS, Ruberg FL, Weinsaft JW. More Than Meets the Eye: Time for a New Imaging Paradigm to Test for Cardiac Amyloidosis. J Card Fail. 2018 Feb; 24(2):87-89. PMID: 29305971.
-
Arvanitis M, Chan GG, Jacobson DR, Berk JL, Connors LH, Ruberg FL. Prevalence of mutant ATTR cardiac amyloidosis in elderly African Americans with heart failure. Amyloid. 2017 Dec; 24(4):253-255.View Related Profiles. PMID: 29052438.
-
Salinaro F, Meier-Ewert HK, Miller EJ, Pandey S, Sanchorawala V, Berk JL, Seldin DC, Ruberg FL. Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2017 Sep 01; 18(9):1057-1064.View Related Profiles. PMID: 27965280; DOI: 10.1093/ehjci/jew298;.
-
Arun M, Brauneis D, Doros G, Shelton AC, Sloan JM, Quillen K, Ruberg FL, Sanchorawala V, Varga C. The incidence of atrial fibrillation among patients with AL amyloidosis undergoing high-dose melphalan and stem cell transplantation: experience at a single institution. Bone Marrow Transplant. 2017 09; 52(9):1349-1351.View Related Profiles. PMID: 28737773.
Showing 10 of 70 results.
Show More
-
Siddiqi OK, Ruberg FL. Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment. Trends Cardiovasc Med. 2018 Jan; 28(1):10-21.View Related Profiles. PMID: 28739313.
-
-
-
-
Arvanitis M, Simon S, Chan G, Fine D, Beardsley P, LaValley M, Jacobson D, Koch C, Berk JL, Connors LH, Ruberg FL. Retinol binding protein 4 (RBP4) concentration identifies V122I transthyretin cardiac amyloidosis. Amyloid. 2017 Mar; 24(sup1):120-121.View Related Profiles. PMID: 28434357; DOI: 10.1080/13506129.2017.1295371;.
-
Maurer M, Lousada I, Hanna M, Ruberg F, Mohty D, Dispenzieri A, Liedtke M, Paulson I, Vest J, Grogan M. Recommendations from the Amyloidosis Research Consortium Educational Roundtable at the American College of Cardiology Annual Meeting, 1 April 2016. Amyloid. 2017 Mar; 24(sup1):165-166. PMID: 28434366; DOI: 10.1080/13506129.2017.1286582;.
-
Arvanitis M, Koch CM, Chan GG, Torres-Arancivia C, LaValley MP, Jacobson DR, Berk JL, Connors LH, Ruberg FL. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model. JAMA Cardiol. 2017 Mar 01; 2(3):305-313.View Related Profiles. PMID: 28196196; DOI: 10.1001/jamacardio.2016.5864;.
-
Buxbaum JN, Ruberg FL. Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans. Genet Med. 2017 Jul; 19(7):733-742. PMID: 28102864; DOI: 10.1038/gim.2016.200;.
-
Ruberg FL, Fontana M, Gillmore JD. Should Histologic Determination of Amyloid Load Determine Management Decisions in Light-Chain Amyloidosis? J Am Coll Cardiol. 2016 12 06; 68(22):2493-2494. PMID: 27908360; DOI: 10.1016/j.jacc.2016.07.786;.
-
Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, Pozniakoff T, Ruberg FL, Miller EJ, Berk JL, Dispenzieri A, Grogan M, Johnson G, Bokhari S, Maurer MS. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis. JAMA Cardiol. 2016 11 01; 1(8):880-889.View Related Profiles. PMID: 27557400; DOI: 10.1001/jamacardio.2016.2839;.
-
Haq M, Pawar S, Berk JL, Miller EJ, Ruberg FL. Can 99mTc-Pyrophosphate Aid in Early Detection of Cardiac Involvement in Asymptomatic Variant TTR Amyloidosis? JACC Cardiovasc Imaging. 2017 Jun; 10(6):713-714.View Related Profiles. PMID: 27568122; DOI: 10.1016/j.jcmg.2016.06.003;.
-
Ahmadian A, Pawar S, Govender P, Berman J, Ruberg FL, Miller EJ. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis. J Nucl Cardiol. 2017 Apr; 24(2):413-424.View Related Profiles. PMID: 27457527; DOI: 10.1007/s12350-016-0490-7;.
-
Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016 Jun 14; 133(24):2404-12.View Related Profiles. PMID: 27143678; DOI: 10.1161/CIRCULATIONAHA.116.021612;.
-
Jefferson AL, Gifford KA, Acosta LM, Bell SP, Donahue MJ, Davis LT, Gottlieb J, Gupta DK, Hohman TJ, Lane EM, Libon DJ, Mendes LA, Niswender K, Pechman KR, Rane S, Ruberg FL, Su YR, Zetterberg H, Liu D. The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview. J Alzheimers Dis. 2016 03 08; 52(2):539-59.View Related Profiles. PMID: 26967211; PMCID: PMC4866875; DOI: 10.3233/JAD-150914;.
-
Connors LH, Sam F, Skinner M, Salinaro F, Sun F, Ruberg FL, Berk JL, Seldin DC. Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort Study. Circulation. 2016 Jan 19; 133(3):282-90.View Related Profiles. PMID: 26660282; PMCID: PMC4718760; DOI: 10.1161/CIRCULATIONAHA.115.018852;.
-
-
-
-
Jefferson AL, Hohman TJ, Liu D, Haj-Hassan S, Gifford KA, Benson EM, Skinner JS, Lu Z, Sparling J, Sumner EC, Bell S, Ruberg FL. Adverse vascular risk is related to cognitive decline in older adults. J Alzheimers Dis. 2015; 44(4):1361-73.View Related Profiles. PMID: 25471188; PMCID: PMC4336578; DOI: 10.3233/JAD-141812;.
-
Ahmadian A, Brogan A, Berman J, Sverdlov AL, Mercier G, Mazzini M, Govender P, Ruberg FL, Miller EJ. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol. 2014 Oct; 21(5):925-39.View Related Profiles. PMID: 24879453; DOI: 10.1007/s12350-014-9901-9;.
-
Hua N, Chen Z, Phinikaridou A, Pham T, Qiao Y, LaValley MP, Bigornia SJ, Ruth MR, Apovian CM, Ruberg FL, Hamilton JA. The influence of pericardial fat upon left ventricular function in obese females: evidence of a site-specific effect. J Cardiovasc Magn Reson. 2014; 16:37.View Related Profiles. PMID: 24884541; PMCID: PMC4046092; DOI: 10.1186/1532-429X-16-37;.
-
Berman JS, Govender P, Ruberg FL, Mazzini M, Miller EJ. Scadding revisited: a proposed staging system for cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014; 31(1):2-5.View Related Profiles. PMID: 24751447.
-
Girnius S, Seldin DC, Meier-Ewert HK, Sloan JM, Quillen K, Ruberg FL, Berk JL, Doros G, Sanchorawala V. Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement. Bone Marrow Transplant. 2014 Mar; 49(3):434-9.View Related Profiles. PMID: 24317129; DOI: 10.1038/bmt.2013.192;.
-
Ruberg FL. T1 mapping in cardiac amyloidosis: can we get there from here? JACC Cardiovasc Imaging. 2013 Apr; 6(4):498-500. PMID: 23498671; DOI: 10.1016/j.jcmg.2013.01.007;.
-
-
Tsai SB, Seldin DC, Quillen K, Berk JL, Ruberg FL, Meier-Ewert H, Sloan JM, Doros G, Finn KT, Skinner M, Sanchorawala V. High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center. Blood. 2012 Nov 22; 120(22):4445-6.View Related Profiles. PMID: 23175664; DOI: 10.1182/blood-2012-09-457341;.
-
-
Ruberg FL, Maurer MS, Judge DP, Zeldenrust S, Skinner M, Kim AY, Falk RH, Cheung KN, Patel AR, Pano A, Packman J, Grogan DR. Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS). Am Heart J. 2012 Aug; 164(2):222-228.e1.View Related Profiles. PMID: 22877808; DOI: 10.1016/j.ahj.2012.04.015;.
-
Freeman B, Sloan JM, Seldin DC, Cowan AJ, Ruberg FL, Sanchorawala V. Multiple arterial and venous thromboembolic complications in AL amyloidosis and cardiac involvement: a case report and literature review. Amyloid. 2012 Sep; 19(3):156-60.View Related Profiles. PMID: 22680044; DOI: 10.3109/13506129.2012.694825;.
-
-
Cibeira MT, Sanchorawala V, Seldin DC, Quillen K, Berk JL, Dember LM, Segal A, Ruberg F, Meier-Ewert H, Andrea NT, Sloan JM, Finn KT, Doros G, Blade J, Skinner M. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood. 2011 Oct 20; 118(16):4346-52.View Related Profiles. PMID: 21828140; PMCID: PMC3204906; DOI: 10.1182/blood-2011-01-330738;.
-
Seldin DC, Andrea N, Berenbaum I, Berk JL, Connors L, Dember LM, Doros G, Fennessey S, Finn K, Girnius S, Lerner A, Libbey C, Meier-Ewert HK, O'Connell R, O'Hara C, Quillen K, Ruberg FL, Sam F, Segal A, Shelton A, Skinner M, Sloan JM, Wiesman JF, Sanchorawala V. High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution. Amyloid. 2011 Jun; 18 Suppl 1:127-9.View Related Profiles. PMID: 21838459; DOI: 10.3109/13506129.2011.574354047;.
-
Meier-Ewert HK, Sanchorawala V, Berk J, Finn KT, Skinner M, Seldin DC, Ruberg FL. Regression of cardiac wall thickness following chemotherapy and stem cell transplantation for light chain (AL) amyloidosis. Amyloid. 2011 Jun; 18 Suppl 1:130-1.View Related Profiles. PMID: 21838460; DOI: 10.3109/13506129.2011.574354048;.
-
Tsai SB, Seldin DC, Wu H, O'Hara C, Ruberg FL, Sanchorawala V. Myocardial infarction with "clean coronaries" caused by amyloid light-chain AL amyloidosis: a case report and literature review. Amyloid. 2011 Sep; 18(3):160-4.View Related Profiles. PMID: 21504342; DOI: 10.3109/13506129.2011.571319;.
-
Bhuiyan T, Helmke S, Patel AR, Ruberg FL, Packman J, Cheung K, Grogan D, Maurer MS. Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS). Circ Heart Fail. 2011 Mar; 4(2):121-8. PMID: 21191093; DOI: 10.1161/CIRCHEARTFAILURE.109.910455;.
-
Ruberg FL. Paying at the pump: diet-induced accumulation of cardiac lipid and systolic dysfunction. Circ Cardiovasc Imaging. 2010 Nov; 3(6):635-7. PMID: 21081742; DOI: 10.1161/CIRCIMAGING.110.960476;.
-
Amsterdam EA, Kirk JD, Bluemke DA, Diercks D, Farkouh ME, Garvey JL, Kontos MC, McCord J, Miller TD, Morise A, Newby LK, Ruberg FL, Scordo KA, Thompson PD. Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association. Circulation. 2010 Oct 26; 122(17):1756-76. PMID: 20660809; PMCID: PMC3044644; DOI: 10.1161/CIR.0b013e3181ec61df;.
-
-
Ruberg FL, Chen Z, Hua N, Bigornia S, Guo Z, Hallock K, Jara H, LaValley M, Phinikaridou A, Qiao Y, Viereck J, Apovian CM, Hamilton JA. The relationship of ectopic lipid accumulation to cardiac and vascular function in obesity and metabolic syndrome. Obesity (Silver Spring). 2010 Jun; 18(6):1116-21.View Related Profiles. PMID: 19875992; PMCID: PMC3264050; DOI: 10.1038/oby.2009.363;.
-
Ruberg FL, Judge DP, Maurer MS. Familial amyloid cardiomyopathy due to TTR mutations: an underdiagnosed cause of restrictive cardiomyopathy [corrected]. J Card Fail. 2009 Jun; 15(5):464. PMID: 19477408; DOI: 10.1016/j.cardfail.2009.04.003;.
-
Ruberg FL, Appelbaum E, Davidoff R, Ozonoff A, Kissinger KV, Harrigan C, Skinner M, Manning WJ. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol. 2009 Feb 15; 103(4):544-9.View Related Profiles. PMID: 19195518; PMCID: PMC2680134; DOI: 10.1016/j.amjcard.2008.09.105;.
-
Goyal SK, Punnam SR, Verma G, Ruberg FL. Persistent left superior vena cava: a case report and review of literature. Cardiovasc Ultrasound. 2008; 6:50. PMID: 18847480; PMCID: PMC2576163; DOI: 10.1186/1476-7120-6-50;.
-
Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, O'Donnell CJ, Fox CS. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008 Feb 5; 117(5):605-13.View Related Profiles. PMID: 18212276; DOI: 10.1161/CIRCULATIONAHA.107.743062;.
-
-
Ruberg FL. Myocardial lipid accumulation in the diabetic heart. Circulation. 2007 Sep 4; 116(10):1110-2. PMID: 17768302.
-
Qiao Y, Ronen I, Viereck J, Ruberg FL, Hamilton JA. Identification of atherosclerotic lipid deposits by diffusion-weighted imaging. Arterioscler Thromb Vasc Biol. 2007 Jun; 27(6):1440-6.View Related Profiles. PMID: 17379838; PMCID: PMC2910580.
-
Ruberg FL, McDonnell ME, Trabb J, Shemin RJ, Hoyt RF, Braverman LE, Balady GJ. An intracardiac accessory thyroid gland. Am J Cardiol. 2006 Mar 15; 97(6):926-8.View Related Profiles. PMID: 16516604.
-
Davidoff R, Ruberg FL. Newer cardiac imaging techniques: multidetector CT angiography. J Insur Med. 2006; 38(2):116-25.View Related Profiles. PMID: 16845845.
-
Ruberg FL, Loscalzo J. Normal Mechanisms of Hemostasis. In: Loscalzo J, Dzau V, and Creager M, eds. Vascular Medicine, A Companion to Braunwald’s Heart Disease. Saunders/Elsevier. Philadelphia. 2006; 61-70.
-
Ruberg FL, Viereck J, Phinikaridou A, Qiao Y, Loscalzo J, Hamilton JA. Identification of cholesteryl esters in human carotid atherosclerosis by ex vivo image-guided proton MRS. J Lipid Res. 2006 Feb; 47(2):310-7.View Related Profiles. PMID: 16317172.
-
Ruberg FL, Kissinger KV, Manning WJ. Images in cardiovascular medicine. Diaphragmatic motion during Cheyne-Stokes respiration by navigator magnetic resonance imaging. Circulation. 2005 Sep 6; 112(10):e132. PMID: 16145007.
-
Ruberg FL. Computed Tomography of the Coronary Arteries. Book Review: Circulation 112:e7-8. 2005.
-
Ruberg FL, Loscalzo J. Vascular Thromboresistance and the Genetics of Thrombotic Risk. In: Becker RC and Harrington RA, eds. Clinical, Interventional and Investigational Thrombocardiology. Taylor and Francis. London. 2005; 31-53.
-
Ruberg FL, Loscalzo J. Inflammation and Atherothrombosis. In: Loscalzo J, ed. Molecular Mechanisms of Atherosclerosis. Taylor and Francis. London. 2005; 45-60.
-
Viereck J, Ruberg FL, Qiao Y, Perez AS, Detwiller K, Johnstone M, Hamilton JA. MRI of atherothrombosis associated with plaque rupture. Arterioscler Thromb Vasc Biol. 2005 Jan; 25(1):240-5.View Related Profiles. PMID: 15528478.
-
Ruberg FL, Leopold JA, Loscalzo J. Atherothrombosis: plaque instability and thrombogenesis. Prog Cardiovasc Dis. 2002 Mar-Apr; 44(5):381-94. PMID: 12024336.
-
Ruberg FL, Loscalzo J. Prothrombotic determinants of coronary atherothrombosis. Vasc Med. 2002; 7(4):289-99. PMID: 12710845.
-
O'Brien CD, Ji G, Wang YX, Sun J, Krymskaya VP, Ruberg FL, Kotlikoff MI, Albelda SM. PECAM-1 (CD31) engagement activates a phosphoinositide-independent, nonspecific cation channel in endothelial cells. FASEB J. 2001 May; 15(7):1257-60. PMID: 11344106.
-
Gurubhagavatula I, Amrani Y, Pratico D, Ruberg FL, Albelda SM, Panettieri RA. Engagement of human PECAM-1 (CD31) on human endothelial cells increases intracellular calcium ion concentration and stimulates prostacyclin release. J Clin Invest. 1998 Jan 1; 101(1):212-22. PMID: 9421484; PMCID: PMC508558.
-
Ruberg FL, Skene DJ, Hanifin JP, Rollag MD, English J, Arendt J, Brainard GC. Melatonin regulation in humans with color vision deficiencies. J Clin Endocrinol Metab. 1996 Aug; 81(8):2980-5. PMID: 8768862.
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
| Year | Publications |
|---|
| 1996 | 1 |
| 1998 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 5 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 6 |
| 2017 | 11 |
| 2018 | 7 |
Dr. Ruberg is the Director, Pilot Grants Program, BU CTSI and an Associate Professor of Medicine and Radiology at Boston University School of Medicine. Dr. Ruberg is also the Director of the Cardiovascular Medicine Fellowship Training Program. An active clinical cardiologist and investigator, Dr. Ruberg’s commitment to interdisciplinary research and team science is exemplified by his various responsibilities at BUMC. He is the Director of the Advanced Cardiac Imaging Program at Boston Medical Center – a clinical service involving clinicians and trainees in the Departments of Radiology and Medicine. His clinical interest is in infiltrative cardiomyopathy and he is a participating clinician and researcher in the multi-disciplinary BU Amyloidosis Center and Sarcoidosis Center. He is a nationally recognized expert in cardiac amyloidosis. His clinical and research expertise is in the field of cardiac imaging with interest in refining quantitative MR techniques for application in the clinical care of infiltrative cardiomyopathies. His research has been funded by the American Heart Association (AHA), Amyloidosis Foundation, and NIH. In addition to his own grant awards, Dr. Ruberg is also co-investigator on both BUMC and outside BMC collaborative projects, including the NIH-funded Vanderbilt Memory and Alzheimer’s Center. Dr. Ruberg is a peer reviewer for numerous journals including Circulation, Annals of Internal Medicine, Journal of the American College of Cardiology, and JACC: Cardiovascular Imaging. He has served as an NIH peer reviewer and is a member of the editorial board of Circulation: Cardiovascular Imaging. Dr. Ruberg is a fellow of the American College of Cardiology and the AHA.
Dr. Ruberg is an active mentor of Internal Medicine residents and Cardiovascular Medicine fellows. Past projects have involved cardiac imaging and past mentees have reported finding at the major national Cardiology meetings and published reports in the peer reviewed literature.
Available to Mentor as: (Review Mentor Role Definitions):
-
Advisor
-
Career Mentor
-
Co-Mentor or Peer Mentor
-
Diversity Mentor
-
Project Mentor
-
Research / Scholarly Mentor
-
Work / Life Integration Mentor
75 E. Newton St Collamore Building
Boston MA 02118
Google Map